Generic biosimilar insulin glargine products have also begun to enter the market, potentially reducing costs for patients who need this medication class
This combination of efficacy, familiarity, and convenience positions oral semaglutide as a compelling option for practices already offering medical weight lossor those considering adding it
Moreover, GLP-1RA and DPP-4 inhibitors are approved for the treatment of T2DM and exhibit potential pleiotropic effects on the heart and kidneys, which may be independent of or dependent on the hypoglycemic effects
Grauslund, J., Abou Taha, A., Dehghani Molander, L., Kawasaki, R., Mller, S., Hjlund, K., & Stokholm, L., Once-weekly semaglutide doubles the five-year risk of nonarteritic anterior ischemic optic neuropathy in a Danish cohort of 424,152 persons with type 2 diabetes, International Journal of Retina and Vitreous , accepted for publication
This is especially true if you have a high-sulfur diet
What is the difference between GLP-1 and GLP-1 + GIP
